Healthcare provider profile · identity verified

Philip Riley

Family Practice · ROCHESTER, MI · NPI 1851820518

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	845	283
Lisinopril	Lisinopril	481	154
Amlodipine Besylate	Amlodipine Besylate	355	123
Omeprazole	Omeprazole	341	117
Losartan Potassium	Losartan Potassium	307	108
Levothyroxine Sodium	Levothyroxine Sodium	286	97
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	265	265
Metoprolol Succinate	Metoprolol Succinate	252	97
Metformin Hcl Er	Metformin Hcl	236	75
Tamsulosin Hcl	Tamsulosin Hcl	211	68
Metformin Hcl	Metformin Hcl	208	79
Allopurinol	Allopurinol	182	58
Gabapentin	Gabapentin	172	48
Duloxetine Hcl	Duloxetine Hcl	171	78
Hydrochlorothiazide	Hydrochlorothiazide	146	46
Pantoprazole Sodium	Pantoprazole Sodium	135	50
Rosuvastatin Calcium	Rosuvastatin Calcium	128	51
Albuterol Sulfate Hfa	Albuterol Sulfate	127	48
Pravastatin Sodium	Pravastatin Sodium	122	44
Jardiance	Empagliflozin	114	37
Famotidine	Famotidine	110	39
Furosemide	Furosemide	107	39
Sertraline Hcl	Sertraline Hcl	107	44
Metoprolol Tartrate	Metoprolol Tartrate	103	37
Ezetimibe	Ezetimibe	89	36
Trazodone Hcl	Trazodone Hcl	84	35
Fluticasone Propionate	Fluticasone Propionate	77	34
Potassium Chloride	Potassium Chloride	77	32
Shingrix	Varicella-Zoster Ge/As01b/Pf	74	63
Atenolol	Atenolol	71	24
Citalopram Hbr	Citalopram Hydrobromide	66	22
Rybelsus	Semaglutide	65	24
Montelukast Sodium	Montelukast Sodium	63	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	14
Eliquis	Apixaban	60	22
Simvastatin	Simvastatin	60	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	16
Clopidogrel	Clopidogrel Bisulfate	53	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	23
Warfarin Sodium	Warfarin Sodium	50	21
Carvedilol	Carvedilol	47	17
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	45	45
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	14
Tramadol Hcl	Tramadol Hcl	44	14
Alprazolam	Alprazolam	43	16
Glipizide	Glipizide	43	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	38
Spironolactone	Spironolactone	42	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	14
Mounjaro	Tirzepatide	39	suppressed
Glipizide Er	Glipizide	38	18
Spiriva Handihaler	Tiotropium Bromide	38	13
Nystatin	Nystatin	37	13
Prednisone	Prednisone	37	28
Meclizine Hcl	Meclizine Hcl	36	25
Buspirone Hcl	Buspirone Hcl	35	16
Venlafaxine Hcl Er	Venlafaxine Hcl	35	13
Bupropion Hcl Sr	Bupropion Hcl	31	20
Ibuprofen	Ibuprofen	31	13
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	15
Doxycycline Hyclate	Doxycycline Hyclate	26	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Meloxicam	Meloxicam	25	16
Pioglitazone Hcl	Pioglitazone Hcl	25	11
Chlorthalidone	Chlorthalidone	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	23	suppressed
Invokana	Canagliflozin	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Tiotropium Bromide	Tiotropium Bromide	21	13
Triamcinolone Acetonide	Triamcinolone Acetonide	21	19
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Oxycontin	Oxycodone Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Finasteride	Finasteride	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Ozempic	Semaglutide	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Colchicine	Colchicine	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Valsartan	Valsartan	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	11
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Repatha Syringe	Evolocumab	14	suppressed
Azithromycin	Azithromycin	13	13
Benazepril Hcl	Benazepril Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nyamyc	Nystatin	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Terazosin Hcl	Terazosin Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Diazepam	Diazepam	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ramipril	Ramipril	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error